17 results
8-K
EX-99.1
LTRN
Lantern Pharma Inc
9 Aug 23
Lantern Pharma Reports Second Quarter 2023 Financial Results and Operational Highlights
4:05pm
, 2023.
“We made significant strides over the past quarter in executing our mission of transforming the oncology drug discovery and development process
8-K
EX-99.1
LTRN
Lantern Pharma Inc
9 May 23
Lantern Pharma Reports First Quarter 2023 Financial Results and Operational Highlights
4:05pm
for the first quarter ended March 31, 2023.
“This quarter we continued to execute our mission of transforming the oncology drug discovery and development
DEF 14A
vb8qybggj8k
9 Apr 21
Definitive proxy
11:30am
10-K
wypbsz 9jzbkdz6afdie
10 Mar 21
Annual report
4:07pm
424B4
eqn5rs
15 Jan 21
Prospectus supplement with pricing info
5:24pm
DRS
aqef116 ymx
16 Dec 20
Draft registration statement
12:00am
424B4
81ku 1125vm4jh
12 Jun 20
Prospectus supplement with pricing info
7:49am
S-1
dv9y06 52e
16 Apr 20
IPO registration
3:32pm
DRS
epgxj wje0ocinxx1
24 Jan 20
Draft registration statement
12:00am
- Prev
- 1
- Next